Oncology Views & Analysis | pharmaphorum

Thursday 28 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

Views & Analysis

Oncology

CAR-T black box

Warning signs for CAR-T after secondary cancer cases

CAR-T treatments emerged as a major success for the pharma industry when first approved in 2017, but this has been muddied by concerns over secondary malignancies.

Oncology

AI in cancer care

Women in life sciences: Miruna Sasu

On International Women’s Day, pharmaphorum looks back to an interview with Miruna Sasu, PhD, CEO of COTA, a real-world data company that is advancing generative AI models for cancer care.

Oncology

12 Questions with Jorge Reis-Filho

Sponsored

12 Questions with Jorge Reis-Filho

As Vice President of Cancer Biomarker Development at AstraZeneca, Jorge Reis-Filho seeks to develop and validate the next generation of mechanistically informed and clinically deployable bi

Oncology

language in cancer care

Words matter: The power of language in cancer discussions

The priority for any individual diagnosed with cancer is to be provided an effective therapy as quickly as possible.

Oncology

investment growth

Why is pharma going gaga for radiopharmaceuticals?

The pharma industry is always on the lookout for new therapeutic angles that might prove to be a competitive advantage.

Oncology

Case Study: MGI and Alacris Theranostics

Sponsored

Case Study: MGI and Alacris Theranostics

As World Cancer Day approached this year, the increasing focus on precision oncology continued apace.